This site is intended for Healthcare Professionals only.

Tag: triple negative breast cancer

spot_imgspot_img

NHS introduces ‘Pembrolizumab’ to treat triple-negative breast cancer

The NHS has secured a deal for ‘Pembrolizumab’ to treat women with triple-negative breast cancer. Up to 1,600 women a year affected by high risk...

NICE recommends new injectable immunotherapy treatment for rare triple negative breast cancer

The National Institute for Health and Care Excellence (NICE) has recommended pembrolizumab in combination with chemotherapy (paclitaxel or nab-paclitaxel) (Injectable immunotherapy treatment) which is...

NICE says ‘highly effective’ breast cancer drug is ‘too expensive’ for NHS use

Sacituzumab govitecan, a 'highly effective' treatment for triple negative breast cancer, is not recommended by the National Institute for Health and Care Excellence (NICE)...